Private label skincare: what you are actually buying

A private label manufacturer keeps a library of developed, tested, production-ready base formulas. You select a base, then specify what becomes yours: fragrance, colour, active concentration within the range the base can carry, texture adjustments, pack, artwork. The factory produces it under your brand name.

The base chemistry may be shared. The finished product is built to your brief and, in a reasonable agreement, is not offered to anyone else in that exact configuration. You are buying a head start on formulation, not a formula.

Speed. A private label SKU moves from brief to first production run in weeks. Bespoke development runs in quarters, because every new formula needs stability data and preservative efficacy testing before anyone can sell it, and those tests take the time they take regardless of how much you pay.

A minimum you can afford. Development cost has already been absorbed across every brand using that base. You are paying for your run, not for the chemistry behind it.

De-risked chemistry. The base has been through stability and challenge testing and has been produced before. The failure modes are known. On a first bespoke formula they are not, and you discover them on your batch.

The base. If you leave, you leave with your artwork, your fragrance brief and your pack specification — not with the chemistry. Any manufacturer who tells you otherwise is either describing contract manufacturing or being careless with the word.

This matters more than founders expect at the point of switching supplier. It is survivable: a competent factory can work back from a sample and reproduce the feel, the hold, the slip. It is not instant, and the brands that handle it well plan the transition a season ahead rather than discovering the problem when a supplier relationship ends.

The number quoted in a first email is usually per order. The number that governs your launch is per SKU — and often per variant within an SKU, because a different fragrance or a different shade is a separate production run, a separate cleaning cycle and a separate batch record.

This is the single most common place a launch plan breaks. A founder plans six scents, is quoted a minimum they can afford, and discovers the figure applies to each scent. The range becomes six times the capital it was supposed to be, and the realistic answer — launch two, add the rest once something sells — arrives three months later than it should have.

Ask for the minimum per SKU and per variant before you design the range. We will not publish a single figure here because it genuinely moves with the format, the pack and the volume; a 1000 ml shampoo and a 30 ml serum do not share an answer. But any manufacturer should give you a firm one for your specific list within a day of seeing it.

A quote with one number in it is not a quote. The ones worth comparing separate the unit cost of the bulk from the pack, the pack from the decoration, and all of it from the one-off costs — artwork setup, mould or tooling if the pack is not standard, sampling, and the testing the new configuration triggers.

Watch for what is excluded. Stability and challenge testing on a modified formula is often quoted separately and is not optional. Regulatory documentation for the destination market may or may not be included. Shipping terms change the comparison entirely: an EXW price and a DAP price are not the same number wearing different clothes.

The cheapest quote in a set of four is usually the one that has left something out. Find out what before you choose it.

When the formula is the brand. If your positioning rests on an ingredient nobody else has, a concentration the base cannot carry, or a claim you intend to defend commercially, private label will frustrate you — and the version of it you can get will be copied by the next brand your manufacturer signs.

When you need a texture or delivery system that does not exist in any library. A base can be adjusted; it cannot be turned into something structurally different.

In both cases the answer is contract manufacturing, where the formula is developed for you and the specification is yours. It costs more, takes longer, and is the correct decision roughly as often as founders think it is the correct decision minus about two thirds.

Launch two or three SKUs on private label. Find out whether anyone wants them. Use the revenue and the data to decide which single product deserves bespoke development, and move that one to contract manufacturing once the volume justifies owning the chemistry.

The mistake we see most often is the reverse: full development on a first product, before the market has said anything, with the capital that should have gone into acquisition.